James Patrick Tursi - Dec 1, 2023 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role: Director
Signature: /s/ Phillip D. Torrence, by Power of Attorney
Stock symbol: NRBO
Transactions as of: Dec 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/4/2023, 05:12 PM
Previous filing: Nov 2, 2023
Next filing: Jun 7, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NRBO	Common Stock	Award	$0	+25K		$0.00	25K	Dec 1, 2023	Direct	F1, F2
transaction	NRBO	Common Stock	Award	$0	+7.16K	+28.63%	$0.00	32.2K	Dec 1, 2023	Direct	F1, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
F2	50% of the RSUs immediately vested on the grant date, and the remainder will vest in two equal installments on each subsequent anniversary of the grant date, subject to continuing service.
F3	Vests on the earlier of December 1, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.